Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Year: 2022
CytomX Therapeutics to Outline 2023 Company Priorities and Provide Pipeline Update on January 5, 2023
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22 for the treatment of r/r B-cell ALL
The first patient completed the 28-day Dose Limiting Toxicity (DLT) observation period without complication NEW…
Mersana Therapeutics Announces Research Collaboration and Commercial License Agreement with Merck KGaA, Darmstadt, Germany to Develop Novel Immunosynthen Antibody-Drug Conjugates
Collaboration focuses on discovering novel STING-agonist ADCs for up to two targets leveraging Mersana’s proprietary…
3iQ Supports Legal Measures Taken by Fir Tree Capital Management to Unlock the $4.5 Billion-Plus of Trapped Value to GBTC Shareholders
Toronto, Ontario–(Newsfile Corp. – December 22, 2022) – 3iQ strongly believes that many of GBTC’s…
Cybeats Applauds SBOM Mandates Outlined in $1.7 Trillion Omnibus Appropriations Bill
Toronto, Ontario–(Newsfile Corp. – December 22, 2022) – Cybeats Technologies Corp. (CSE: CYBT) (“Cybeats” or the “Company”) is…
Macquarie Global Infrastructure Total Return Fund Inc. Announces Date of Reorganization Into abrdn Global Infrastructure Income Fund
NEW YORK–(BUSINESS WIRE)–Today, Macquarie Global Infrastructure Total Return Fund Inc. (the “Fund”), a New York…
Delaware Investments® Dividend and Income Fund, Inc., Delaware Enhanced Global Dividend and Income Fund, and Delaware Ivy High Income Opportunities Fund Announce Date of Reorganizations
PHILADELPHIA–(BUSINESS WIRE)–Today, the Board of Directors/Trustees of Delaware Investments Dividend and Income Fund (NYSE: “DDF”),…
Kingstone Board of Directors Issues Open Letter to Stockholders Highlighting Strategic Progress and Focus on Value Creation
KINGSTON, N.Y.–(BUSINESS WIRE)–Kingstone Companies, Inc. (Nasdaq:KINS) (the “Company” or “Kingstone”), a Northeast regional property and…
Safe & Green Holdings Corp. Announces Appointment of Shafron Hawkins to Board of Directors
Shafron Hawkins, current president of Opportunity Funds Association, to join Safe & Green Holdings board…
FHLBank Pittsburgh Awards $1.5 Million to Four MVB Bank-Sponsored Affordable Housing Projects in North Central West Virginia
FAIRMONT, W.Va.–(BUSINESS WIRE)–#AHP–FHLBank Pittsburgh (“FHLBank”) has awarded a total of $1.5 million to four North…
BluWave Achieves Record Milestones in 2022
Firm expands headcount and doubles office space in response to increasing demand NASHVILLE, Tenn.–(BUSINESS WIRE)–BluWave,…
Lindsay Corporation Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast
OMAHA, Neb.–(BUSINESS WIRE)–Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and…
VICI Properties Inc. and Foundation Gaming Announce Sale Leaseback Transaction
– Further Diversifies VICI’s Tenant Roster Through Long-Term Partnership with Foundation Gaming – – Regional…
Limoneira Company Announces Fiscal Fourth Quarter and Full Year 2022 Financial Results
Revenue Grew 11% to a Record $184.6 Million in Fiscal Year 2022 Compared to Prior…
Economics Partners Expands Advanced Business Valuation Expertise with Addition of Kevin Yeanoplos
-Technical Advisor Role Deepens Advanced Valuation Analysis in Legal Disputes, Employee Stock Ownership Plans (ESOPs),…
CasaWire, Newest Release from Wire Holdings, Debuts in the App Store
Global home décor, interior design brands, customers connect via digital marketplace platform SEATTLE–(BUSINESS WIRE)–CasaWire, the…
Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
AB Science announces the drawdown of the first tranche of 6 million euros under its financing agreement with the European Investment Bank
PRESS RELEASE AB SCIENCE ANNOUNCES THE DRAWDOWN OF THE FIRST TRANCHE OF 6 MILLION EUROS…
Nova Mentis Receives Health Canada Approval for First-Of-Its-Kind Psilocybin Clinical Trial
The human study will evaluate the Company’s proprietary psilocybin drug (NM-1001) in the treatment of…